CLAUDIA GRANADOS: Open Payments
NPI 1336895523 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 56 payments from 16 companies in 2025. Trend: 2023 $595 · 2024 $1,025 · 2025 $1,618
Food & beverage: $1,618
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $327 |
| Novo Nordisk Inc | 8 | $271 |
| Axsome Therapeutics, Inc. | 7 | $212 |
| Phathom Pharmaceuticals, Inc. | 3 | $191 |
| ABBVIE INC. | 11 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $35 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: Auvelity, BREZTRI, VOQUEZNA, Kerendia, Rybelsus, Ozempic, UBRELVY, QULIPTA.
Industry payments across TX — which companies pay providers there.
